# AndersonBrecon Inc. – FDA Inspection, Jan 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/547fb415-fdae-4a35-9142-319885539957
Source feed: FDA_Inspections

> FDA inspection 1077016 of AndersonBrecon Inc., January 10, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077016
- Company Name: AndersonBrecon Inc.
- Inspection Date: 2019-01-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1271016 - 2025-05-08](https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/d11ee7d4-9b8a-4a35-9d14-5a414fa4bbdc)
- [FDA Inspection 1163069 - 2022-02-25](https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/90d459ea-2526-4230-863a-0094a84a4c0b)
- FDA Inspection 983024 - 2016-07-19
- FDA Inspection 849321 - 2013-09-20
- FDA Inspection 748939 - 2011-10-07

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sarah-e-rhoades/d965990c-15cc-4722-b2d0-aea7206c71b0)

Company: https://www.keypedia.com/companies/andersonbrecon-inc/aefafff0-9d39-4b82-8ebb-44c17e5d0f6d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
